Alternative Models for Carcinogenicity Testing: Weight of Evidence Evaluations Across Models
暂无分享,去创建一个
[1] S. Johansson,et al. Uroepithelial tumors of the renal pelvis associated with abuse of phenacetin‐containing analgesics , 1974, Cancer.
[2] S. Johansson,et al. Tumours of urinary bladder and ureter associated with abuse of phenacetin-containing analgesics. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[3] H. Isaka,et al. Tumors of Sprague-Dawley rats induced by long-term feeding of phenacetin. , 1979, Gan.
[4] S. Johansson,et al. Carcinogenicity of analgesics: Long‐term treatment of sprague‐dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen) , 1981, International journal of cancer.
[5] S. Fukushima,et al. Carcinogenicity of phenacetin: Long‐term feeding study in B6C3F1 mice , 1982, International journal of cancer.
[6] I A Mjör,et al. Consensus Report , 1985, Journal of dental research.
[7] J. Huff,et al. Refinement of Long-Term Toxicity and Carcinogenesis Studies1 , 1990, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[8] R. Maronpot,et al. Rodent Carcinogenicity Bioassay: Past, Present, and Future , 1994, Toxicologic pathology.
[9] R. Tennant,et al. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. , 1995, Environmental health perspectives.
[10] J. Swenberg. Bioassay design and MTD setting: old methods and new approaches. , 1995, Regulatory toxicology and pharmacology : RTP.
[11] P. Fu,et al. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay. , 1997, Regulatory toxicology and pharmacology : RTP.
[12] J. Foran,et al. Principles for the selection of doses in chronic rodent bioassays. ILSI Risk Science Working Group on Dose Selection. , 1997, Environmental health perspectives.
[13] H. van Steeg,et al. Transgenic mouse models for the identification of human carcinogens: a European perspective. , 1998, Toxicologic pathology.
[14] I. Purchase,et al. Workshop overview: scientific and regulatory challenges for the reduction, refinement, and replacement of animals in toxicity testing. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[15] S. Cohen. Cell Proliferation and Carcinogenesis , 1998 .
[16] I. Purchase,et al. Workshop Overview: Scientific and Regulatory Challenges for the Reduction, Refinement, and Replacement of Animals in Toxicity Testing 1 , 1998 .
[17] R. Tennant,et al. Genetically altered mouse models for identifying carcinogens. , 1999, IARC scientific publications.
[18] R. Tennant,et al. Review Article: Use of Transgenic Animals for Carcinogenicity Testing: Considerations and Implications for Risk Assessment , 2000 .
[19] D. Rall. LABORATORY ANIMAL TESTS AND HUMAN CANCER* , 2000, Drug metabolism reviews.
[20] N Ito,et al. Early detection of carcinogenic substances and modifiers in rats. , 2000, Mutation research.
[21] J. Caldwell,et al. Mechanisms of Hormonal Carcinogenesis in the p53+/- Hemizygous Knockout Mouse: Studies With Diethylstilbestrol , 2001, Toxicologic pathology.